Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding and 20 Company Profile - Global Forecast to 2026

Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding and 20 Company Profile - Global Forecast to 2026


  • Products Id :- 1000000000128
  • |
  • Pages: 360
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

This report will be delivered within 24 hours of the purchase.

Executive Summary

The global liquid biopsy market is expected to reach nearly USD 6.5 Billion by 2026. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization of new lesions, drug & therapeutic target identifications for cancer treatment are some advantages of liquid biopsies, which improve the safety and efficiency of cancer therapy for patients.

The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, growing public and private funding to support research activities in the field of liquid biopsy and favorable government initiatives, are some of the factors expected to propel the growth of liquid biopsy market in the coming years. Some of the key factors inhibiting the growth of liquid biopsy market includes, clinical utility challenges, lack of sensitivity and specificity of liquid biopsy tests and unclear reimbursement & regulation scenario.

Global Liquid Biopsy Market & Forecast-by Circulating Biomarker

Based on circulating biomarkers, the global liquid biopsy market is being dominated by Circulating Tumor Cells (CTCs).

The circulating tumor DNA (ctDNA) is the second largest segment of the liquid biopsy market.

The cell free DNA (cfDNA) is the third largest segment of the liquid biopsy market.

The extracellular vesicles (EVs) segment is the fastest growing segment during the forecast period.

Global Liquid Biopsy Market & Forecast-by Product

The global liquid biopsy market, by product, is being dominated by Kits and Consumables.

The instruments segment is likely to witness highest growth in the global liquid biopsy market.

The services segment captured least share of the liquid biopsy market.

Global Liquid Biopsy Market & Forecast-by Application

The global liquid biopsy market, by application, is being dominated by oncology application.

Lung cancer and breast cancer accounts for largest share of the liquid biopsy oncology market.

The non-cancer application segment is expected to be the fastest-growing segment in the market during the forecast period.

Global Liquid Biopsy Oncology Market & Forecast-by Clinical Application

On the basis of clinical application, the therapy selection segment is expected to account for largest share of the liquid biopsy market throughout the forecasting period.

Treatment monitoring captured second highest share of the liquid biopsy market in 2018, being followed by the early cancer screening application.

Recurrence monitoring captured least share of the liquid biopsy market.

Global Liquid Biopsy Market & Forecast-by End User

In 2018, Reference laboratories captured largest share of the global liquid biopsy market.

Hospital and Physician laboratories occupied second highest share of the liquid biopsy market in 2018, being followed by Academic and Research Centers.

Global Liquid Biopsy Market & Forecast-by Sample Type

Blood is the most widely used sample type and is expected to remain the largest market during the forecasting period as well.

The urine sample segment is anticipated to witness noticeable growth throughout the forecasting period.

Liquid Biopsy Market & Forecast-Regional Analysis

North America accounted for largest share of the global liquid biopsy market in 2018, followed by Asia Pacific.

In North America, United States accounted for largest share of the liquid biopsy market.

In Europe, Germany and France are the leading market for liquid biopsy.

Asia pacific is likely to be the fastest growing market for liquid biopsy during the forecasting period.

In Asia Pacific, Japan and China are the leading market for liquid biopsy.

Latin America is the fourth largest market for liquid biopsy, being followed by Middle East & Africa.

This is the 2nd edition report on Liquid Biopsy Market by iGATE RESEARCH. The report titled Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding and 20 Company Profile-Global Forecast to 2026 provides a comprehensive assessment of the fast-evolving, high-growth Global Liquid Biopsy Market.

This 360 Page report with 118 Figures and 7 Tables has been analyzed from 15 viewpoints:

1. Global Liquid Biopsy Market & Forecast (2015-2026)

2. Global Liquid Biopsy Market Share & Forecast (2015-2026)

3. Global Liquid Biopsy Market & Forecast-by Circulating Biomarker (2015-2026)

4. Global Liquid Biopsy Market & Forecast-by Product (2015-2026)

5. Global Liquid Biopsy Market & Forecast-by Application (2015-2026)

6. Global Liquid Biopsy Oncology Market & Forecast-By Cancer Types (2015-2026)

7. Global Liquid Biopsy Oncology Market & Forecast-by Clinical Application (2015-2026)

8. Global Liquid Biopsy Market & Forecast-by End User (2015-2026)

9. Global Liquid Biopsy Market & Forecast-by Sample Type (2015-2026)

10. Liquid Biopsy Market & Forecast-Regional Analysis (2015-2026)

11. Liquid Biopsy Market Share & Forecast-Geographical Analysis (2015-2026)

12. Liquid Biopsy Initiatives

13. Liquid Biopsy Companies Financing Details

14. 20 Company Profiles

15. Global Liquid Biopsy Market-Driving Factors & Challenges

Global Liquid Biopsy Market & Forecast-by Circulating Biomarker (2015-2026)

1. Circulating Tumor Cells (CTCs)

2. Circulating Tumor DNA (ctDNA)

3. Cell-Free DNA (cfDNA)

4. Extracellular Vesicles (EVs)

5. Other Circulating Biomarkers

Global Liquid Biopsy Market & Forecast-by Product (2015-2026)

1. Kits and Consumables

2. Instruments

3. Services

Global Liquid Biopsy Market & Forecast-by Application (2015-2026)

1. Oncology Application

Lung Cancer

Breast Cancer

Colorectal Cancer

Prostate Cancer

Gastrointestinal Cancer

Leukaemia

Others

2. Non-Cancer Application

Global Liquid Biopsy Oncology Market & Forecast-by Clinical Application (2015-2026)

1. Therapy Selection

2. Treatment Monitoring

3. Early Cancer Screening

4. Recurrence Monitoring

Global Liquid Biopsy Market & Forecast-by End User (2015-2026)

1. Reference Laboratories

2. Hospitals and Physician Laboratories

3. Academic and Research Centers

4. Other End Users

Global Liquid Biopsy Market & Forecast-by Sample Type (2015-2026)

1. Blood Sample

2. Urine Sample

3. Other Fluids Sample

Liquid Biopsy Market & Forecast-Regional Analysis (2015-2026)

1. North America

United States

Canada

2. Asia Pacific

South Korea

Japan

China

India

Australia

Rest of Asia Pacific

3. Europe

Germany

France

United Kingdom

Italy

Spain

Rest of Europe

4. Middle East & Africa

UAE

Saudi Arabia

Egypt

Rest of Middle East & Africa

5. Latin America

Liquid Biopsy Market-Company Profiles

1. Personal Genome Diagnostics

2. Guardant Health, Inc.

3. Pathway Genomics

4. RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)

5. Trovagene, Inc

6. Cynvenio Biosystems, Inc.

7. Biocept, Inc.

8. ANGLE plc

9. MDxHealth

10. Clearbridge BioMedics Pte Ltd

11. Exosome Diagnostics, Inc

12. Foundation Medicine, Inc

13. Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)

14. Genomic Health

15. Myriad Genetics, Inc

16. Thermo Fisher Scientific, Inc

17. QIAGEN NV

18. Bio-Rad Laboratories, Inc

19. Menarini-Silicon Biosystems

20. GRAIL

Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1. Executive Summary

2. Global Liquid Biopsy Market & Forecast (2015-2026)

3. Global Liquid Biopsy Market Share & Forecast (2015-2026)

3.1 Global Liquid Biopsy Market Share & Forecast-by Circulating Biomarker

3.2 Global Liquid Biopsy Market Share & Forecast-by Product

3.3 Global Liquid Biopsy Market Share & Forecast-by Application

3.4 Global Liquid Biopsy Oncology Market Share & Forecast-by Clinical Application

3.5 Global Liquid Biopsy Oncology Market Share & Forecast-By Cancer Types

3.6 Global Liquid Biopsy Market Share & Forecast-by End User

3.7 Global Liquid Biopsy Market Share & Forecast-by Sample Type

3.8 Liquid Biopsy Market Share & Forecast-Regional Analysis

3.9 Liquid Biopsy Market Share & Forecast-Country Wise Analysis

4. Global Liquid Biopsy Market & Forecast-by Circulating Biomarker (2015-2026)

4.1 Global Liquid Biopsy-Circulating Tumor Cells (CTCs) Market & Forecast

4.2 Global Liquid Biopsy-Circulating Tumor DNA (ctDNA) Market & Forecast

4.3 Global Liquid Biopsy-Cell-Free DNA (cfDNA) Market & Forecast

4.4 Global Liquid Biopsy-Extracellular Vesicles (EVs) Market & Forecast

4.5 Global Liquid Biopsy-Other Circulating Biomarkers Market & Forecast

5. Global Liquid Biopsy Market & Forecast-by Product (2015-2026)

5.1 Global Liquid Biopsy-Kits and Consumables Market & Forecast

5.2 Global Liquid Biopsy-Instruments Market & Forecast

5.3 Global Liquid Biopsy-Services Market & Forecast

6. Global Liquid Biopsy Market & Forecast-by Application (2015-2026)

6.1 Global Liquid Biopsy-Oncology Application Market & Forecast

6.2 Global Liquid Biopsy Oncology Market & Forecast-By Cancer Types

6.2.1 Lung Cancer Liquid Biopsy Market & Forecast

6.2.2 Breast Cancer Liquid Biopsy Market & Forecast

6.2.3 Colorectal Cancer Liquid Biopsy Market & Forecast

6.2.4 Prostate Cancer Liquid Biopsy Market & Forecast

6.2.5 Gastrointestinal Cancer Liquid Biopsy Market & Forecast

6.2.6 Leukaemia Liquid Biopsy Market & Forecast

6.2.7 Others Liquid Biopsy Market & Forecast

6.3 Global Liquid Biopsy-Non-Cancer Application Market & Forecast

7. Global Liquid Biopsy Oncology Market & Forecast-by Clinical Application (2015-2026)

7.1 Global Liquid Biopsy Oncology Application-Therapy Selection Market & Forecast

7.2 Global Liquid Biopsy Oncology Application-Treatment Monitoring Market & Forecast

7.3 Global Liquid Biopsy Oncology Application-Early Cancer Screening Market & Forecast

7.4 Global Liquid Biopsy Oncology Application-Recurrence Monitoring Market & Forecast

8. Global Liquid Biopsy Market & Forecast-by End User (2015-2026)

8.1 Global Liquid Biopsy-Reference Laboratories Market & Forecast

8.2 Global Liquid Biopsy-Hospitals and Physician Laboratories Market & Forecast

8.3 Global Liquid Biopsy-Academic and Research Centers Market & Forecast

8.4 Global Liquid Biopsy-Other End Users Market & Forecast

9. Global Liquid Biopsy Market & Forecast-by Sample Type (2015-2026)

9.1 Global Liquid Biopsy-Blood Sample Market & Forecast

9.2 Global Liquid Biopsy-Urine Sample Market & Forecast

9.3 Global Liquid Biopsy-Other Fluids Sample Market & Forecast

10. Liquid Biopsy Market & Forecast-Regional Analysis (2015-2026)

10.1 North America Liquid Biopsy Market & Forecast

10.2 Asia Pacific Liquid Biopsy Market & Forecast

10.3 Europe Liquid Biopsy Market & Forecast

10.4 Latin America Liquid Biopsy Market & Forecast

10.5 Middle East & Africa Liquid Biopsy Market & Forecast

11. Liquid Biopsy Market Share & Forecast-Geographical Analysis (2015-2026)

11.1 North America Liquid Biopsy Market & Forecast

11.1.1 United States Liquid Biopsy Market & Forecast

11.1.2 Canada Liquid Biopsy Market & Forecast

11.2 Asia Pacific Liquid Biopsy Market & Forecast

11.2.1 South Korea Liquid Biopsy Market & Forecast

11.2.2 Japan Liquid Biopsy Market & Forecast

11.2.3 China Liquid Biopsy Market & Forecast

11.2.4 India Liquid Biopsy Market & Forecast

11.2.5 Australia Liquid Biopsy Market & Forecast

11.2.6 Rest of Asia Pacific Liquid Biopsy Market & Forecast

11.3 Europe Liquid Biopsy Market & Forecast

11.3.1 Germany Liquid Biopsy Market & Forecast

11.3.2 France Liquid Biopsy Market & Forecast

11.3.3 United Kingdom Liquid Biopsy Market & Forecast

11.3.4 Italy Liquid Biopsy Market & Forecast

11.3.5 Spain Liquid Biopsy Market & Forecast

11.3.6 Rest of Europe Liquid Biopsy Market & Forecast

11.4 Middle East & Africa Liquid Biopsy Market & Forecast

11.4.1 UAE Liquid Biopsy Market & Forecast

11.4.2 Saudi Arabia Liquid Biopsy Market & Forecast

11.4.3 Egypt Liquid Biopsy Market & Forecast

11.4.4 Rest of Middle East & Africa Liquid Biopsy Market & Forecast

11.5 Latin America Liquid Biopsy Market & Forecast

12. Liquid Biopsy Initiatives

13. Liquid Biopsy Companies Financing Details

14. Company Profiles

14.1 Personal Genome Diagnostics

14.1.1 Company Overview

14.1.2 Recent Developments / Strategy / Initiatives

14.2 Guardant Health, Inc.

14.2.1 Company Overview

14.2.2 Recent Developments / Strategy / Initiatives

14.3 Pathway Genomics

14.3.1 Company Overview

14.3.2 Recent Developments / Strategy / Initiatives

14.4 RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)

14.4.1 Company Overview

14.4.2 Recent Developments / Strategy / Initiatives

14.5 Trovagene, Inc.

14.5.1 Company Overview

14.5.2 Recent Developments / Strategy / Initiatives

14.6 Cynvenio Biosystems, Inc.

14.6.1 Company Overview

14.6.2 Recent Developments / Strategy / Initiatives

14.7 Biocept, Inc.

14.7.1 Company Overview

14.7.2 Recent Developments / Strategy / Initiatives

14.8 ANGLE plc

14.8.1 Company Overview

14.8.2 Recent Developments / Strategy / Initiatives

14.9 MDxHealth

14.9.1 Company Overview

14.9.2 Recent Developments / Strategy / Initiatives

14.10 Clearbridge BioMedics Pte Ltd

14.10.1 Company Overview

14.10.2 Recent Developments / Strategy / Initiatives

14.11 Exosome Diagnostics, Inc.

14.11.1 Company Overview

14.11.2 Recent Developments / Strategy / Initiatives

14.12 Foundation Medicine, Inc.

14.12.1 Company Overview

14.12.2 Recent Developments / Strategy / Initiatives

14.13 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)

14.13.1 Company Overview

14.13.2 Recent Developments / Strategy / Initiatives

14.14 Genomic Health

14.14.1 Company Overview

14.14.2 Recent Developments / Strategy / Initiatives

14.15 Myriad Genetics, Inc.

14.15.1 Company Overview

14.15.2 Recent Developments / Strategy / Initiatives

14.16 Thermo Fisher Scientific, Inc.

14.16.1 Company Overview

14.16.2 Recent Developments / Strategy / Initiatives

14.17 QIAGEN NV

14.17.1 Company Overview

14.17.2 Recent Developments / Strategy / Initiatives

14.18 Bio-Rad Laboratories, Inc.

14.18.1 Company Overview

14.18.2 Recent Developments / Strategy / Initiatives

14.19 Menarini-Silicon Biosystems

14.19.1 Company Overview

14.19.2 Recent Developments / Strategy / Initiatives

14.20 GRAIL

14.20.1 Company Overview

14.20.2 Recent Developments / Strategy / Initiatives

15. Global Liquid Biopsy Market-Driving Factors

15.1 Rising Applications of Liquid Biopsy Expected to Boost Liquid Biopsy Market

15.2 Personalized Medicine to Spur Use of Liquid Biopsy Tests in Clinical Practice

15.3 Rising Aging Population and Cancer Incidences to Drive Liquid Biopsy Market

15.4 New Liquid Biopsy Product Launches to Fuel Market Revenues

15.5 Increasing Focus of Manufacturers on Research & Development Through Collaborations To bolster Growth of Liquid Biopsy Market

16. Global Liquid Biopsy Market-Challenges

16.1 Limitations in Third-Party Payer Coverage to Restrict Liquid Biopsy Market

16.2 Liquid Biopsy Clinical Utility Challenges

List of Figures:

Figure 2-1: Global-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 2-2: Global-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 3-1: By Circulating Biomarker-Liquid Biopsy Market Share (Percent), 2015-2018

Figure 3-2: By Circulating Biomarker-Forecast for Liquid Biopsy Market Share (Percent), 2019-2026

Figure 3-3: By Product-Liquid Biopsy Market Share (Percent), 2015-2018

Figure 3-4: By Product-Forecast for Liquid Biopsy Market Share (Percent), 2019-2026

Figure 3-5: By Application-Liquid Biopsy Market Share (Percent), 2015-2018

Figure 3-6: By Application-Forecast for Liquid Biopsy Market Share (Percent), 2019-2026

Figure 3-7: By Clinical Application-Liquid Biopsy Oncology Market Share (Percent), 2015-2018

Figure 3-8: By Clinical Application-Forecast for Liquid Biopsy Oncology Market Share (Percent), 2019-2026

Figure 3-9: By End User-Liquid Biopsy Market Share (Percent), 2015-2018

Figure 3-10: By End User-Forecast for Liquid Biopsy Market Share (Percent), 2019-2026

Figure 3-11: By Sample Type-Liquid Biopsy Market Share (Percent), 2015-2018

Figure 3-12: By Sample Type-Forecast for Liquid Biopsy Market Share (Percent), 2019-2026

Figure 4-1: Global Liquid Biopsy-Circulating Tumor Cells (CTCs) Market (Million USD ), 2015-2018

Figure 4-2: Global Liquid Biopsy-Forecast for Circulating Tumor Cells (CTCs) Market (Million USD ), 2019-2026

Figure 4-3: Global Liquid Biopsy-Circulating Tumor DNA (ctDNA) Market (Million USD ), 2015-2018

Figure 4-4: Global Liquid Biopsy-Forecast for Circulating Tumor DNA (ctDNA) Market (Million USD ), 2019-2026

Figure 4-5: Global Liquid Biopsy-Cell-Free DNA (cfDNA) Market (Million USD ), 2015-2018

Figure 4-6: Global Liquid Biopsy-Forecast for Cell-Free DNA (cfDNA) Market (Million USD ), 2019-2026

Figure 4-7: Global Liquid Biopsy-Extracellular Vesicles (EVs) Market (Million USD ), 2015-2018

Figure 4-8: Global Liquid Biopsy-Forecast for Extracellular Vesicles (EVs) Market (Million USD ), 2019-2026

Figure 4-9: Global Liquid Biopsy-Other Circulating Biomarkers Market (Million USD ), 2015-2018

Figure 4-10: Global Liquid Biopsy-Forecast for Other Circulating Biomarkers Market (Million USD ), 2019-2026

Figure 5-1: Global Liquid Biopsy-Kits and Consumables Market (Million USD ), 2015-2018

Figure 5-2: Global Liquid Biopsy-Forecast for Kits and Consumables Market (Million USD ), 2019-2026

Figure 5-3: Global Liquid Biopsy-Instruments Market (Million USD ), 2015-2018

Figure 5-4: Global Liquid Biopsy-Forecast for Instruments Market (Million USD ), 2019-2026

Figure 5-5: Global Liquid Biopsy-Services Market (Million USD ), 2015-2018

Figure 5-6: Global Liquid Biopsy-Forecast for Services Market (Million USD ), 2019-2026

Figure 6-1: Global Liquid Biopsy-Oncology Application Market (Million USD ), 2015-2018

Figure 6-2: Global Liquid Biopsy-Forecast for Oncology Application Market (Million USD ), 2019-2026

Figure 6-3: Global-Lung Cancer Liquid Biopsy Market (Million USD ), 2015-2018

Figure 6-4: Global-Forecast for Lung Cancer Liquid Biopsy Market (Million USD ), 2019-2026

Figure 6-5: Global-Breast Cancer Liquid Biopsy Market (Million USD ), 2015-2018

Figure 6-6: Global-Forecast for Breast Cancer Liquid Biopsy Market (Million USD ), 2019-2026

Figure 6-7: Global-Colorectal Cancer Liquid Biopsy Market (Million USD ), 2015-2018

Figure 6-8: Global-Forecast for Colorectal Cancer Liquid Biopsy Market (Million USD ), 2019-2026

Figure 6-9: Global-Prostate Cancer Liquid Biopsy Market (Million USD ), 2015-2018

Figure 6-10: Global-Forecast for Prostate Cancer Liquid Biopsy Market (Million USD ), 2019-2026

Figure 6-11: Global-Gastrointestinal Cancer Liquid Biopsy Market (Million USD ), 2015-2018

Figure 6-12: Global-Forecast for Gastrointestinal Cancer Liquid Biopsy Market (Million USD ), 2019-2026

Figure 6-13: Global-Leukaemia Cancer Liquid Biopsy Market (Million USD ), 2015-2018

Figure 6-14: Global-Forecast for Leukaemia Cancer Liquid Biopsy Market (Million USD ), 2019-2026

Figure 6-15: Global-Others Liquid Biopsy Market (Million USD ), 2015-2018

Figure 6-16: Global-Forecast for Others Liquid Biopsy Market (Million USD ), 2019-2026

Figure 6-17: Global Liquid Biopsy-Non-Cancer Application Market (Million USD ), 2015-2018

Figure 6-18: Global Liquid Biopsy-Forecast for Non-Cancer Application Market (Million USD ), 2019-2026

Figure 7-1: Global Liquid Biopsy Oncology Application-Therapy Selection Market (Million USD ), 2015-2018

Figure 7-2: Global Liquid Biopsy Oncology Application-Forecast for Therapy Selection Market (Million USD ), 2019-2026

Figure 7-3: Global Liquid Biopsy Oncology Application-Treatment Monitoring Market (Million USD ), 2015-2018

Figure 7-4: Global Liquid Biopsy Oncology Application-Forecast for Treatment Monitoring Market (Million USD ), 2019-2026

Figure 7-5: Global Liquid Biopsy Oncology Application-Early Cancer Screening Market (Million USD ), 2015-2018

Figure 7-6: Global Liquid Biopsy Oncology Application-Forecast for Early Cancer Screening Market (Million USD ), 2019-2026

Figure 7-7: Global Liquid Biopsy Oncology Application-Recurrence Monitoring Market (Million USD ), 2015-2018

Figure 7-8: Global Liquid Biopsy Oncology Application-Forecast for Recurrence Monitoring Market (Million USD ), 2019-2026

Figure 8-1: Global Liquid Biopsy-Reference Laboratories Market (Million USD ), 2015-2018

Figure 8-2: Global Liquid Biopsy-Forecast for Reference Laboratories Market (Million USD ), 2019-2026

Figure 8-3: Global Liquid Biopsy-Hospitals and Physician Laboratories Market (Million USD ), 2015-2018

Figure 8-4: Global Liquid Biopsy-Forecast for Hospitals and Physician Laboratories Market (Million USD ), 2019-2026

Figure 8-5: Global Liquid Biopsy-Academic and Research Centers Market (Million USD ), 2015-2018

Figure 8-6: Global Liquid Biopsy-Forecast for Academic and Research Centers Market (Million USD ), 2019-2026

Figure 8-7: Global Liquid Biopsy-Other End Users Market (Million USD ), 2015-2018

Figure 8-8: Global Liquid Biopsy-Forecast for Other End Users Market (Million USD ), 2019-2026

Figure 9-1: Global Liquid Biopsy-Blood Sample Market (Million USD ), 2015-2018

Figure 9-2: Global Liquid Biopsy-Forecast for Blood Sample Market (Million USD ), 2019-2026

Figure 9-3: Global Liquid Biopsy-Urine Sample Market (Million USD ), 2015-2018

Figure 9-4: Global Liquid Biopsy-Forecast for Urine Sample Market (Million USD ), 2019-2026

Figure 9-5: Global Liquid Biopsy-Other Fluids Sample Market (Million USD ), 2015-2018

Figure 9-6: Global Liquid Biopsy-Forecast for Other Fluids Sample Market (Million USD ), 2019-2026

Figure 10-1: North America-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 10-2: North America-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 10-3: Asia Pacific-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 10-4: Asia Pacific-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 10-5: Europe-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 10-6: Europe-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 10-7: Latin America-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 10-8: Latin America-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 10-9: Middle East & Africa-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 10-10: Middle East & Africa-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-1: United States-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-2: United States-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-3: Canada-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-4: Canada-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-5: South Korea-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-6: South Korea-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-7: Japan-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-8: Japan-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-9: China-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-10: China-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-11: India-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-12: India-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-13: Australia-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-14: Australia-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-15: Rest of Asia Pacific-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-16: Rest of Asia Pacific-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-17: Germany-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-18: Germany-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-19: France-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-20: France-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-21: United Kingdom-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-22: United Kingdom-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-23: Italy-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-24: Italy-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-25: Spain-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-26: Spain-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-27: Rest of Europe-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-28: Rest of Europe-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-29: UAE-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-30: UAE-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-31: Saudi Arabia-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-32: Saudi Arabia-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-33: Egypt-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-34: Egypt-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-35: Rest of Middle East & Africa-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-36: Rest of Middle East & Africa-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

Figure 11-37: Latin America-Liquid Biopsy Market (Million USD ), 2015-2018

Figure 11-38: Latin America-Forecast for Liquid Biopsy Market (Million USD ), 2019-2026

List of Tables:

Table 3-1: By Cancer Types-Liquid Biopsy Oncology Market Share (Percent), 2015-2018

Table 3-2: By Cancer Types-Forecast for Liquid Biopsy Oncology Market Share (Percent), 2019-2026

Table 3-3: By Region-Liquid Biopsy Market Share (Percent), 2015-2018

Table 3-4: By Region-Forecast for Liquid Biopsy Market Share (Percent), 2019-2026

Table 3-5: By Country-Liquid Biopsy Market Share (Percent), 2015-2018

Table 3-6: By Country-Forecast for Liquid Biopsy Market Share (Percent), 2019-2026

Table 14-1: Clearbridge BioMedics-Distributors in EMEA and APAC Regions

"Single User License - PDF:

A PDF version of the report will be mailed by iGATE Research to the clients email address.

CD-Rom Mail Delivery:

A CD-Rom with a copy of report will be sent by iGATE Research to the provided shipping address of the clients.

Hard Copy Mail Delivery:

A hard copy of the report will be shipped by iGATE Research to the shipping address.

Multi-User License:

A Multi-User License provides an effective way to avoid copyright violations by granting discounted, multi-user use for a report. It allows employees to share a report with other Authorized Users, any person employed by the same direct organization of the original purchaser. This does not extend to employees of the parent company or related subsidiaries."

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Personal Genome Diagnostics, Guardant Health, Inc., Pathway Genomics, RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.), Trovagene, Inc, Cynvenio Biosystems, Inc., Biocept, Inc., ANGLE plc, MDxHealth, Clearbridge BioMedics Pte Ltd, Exosome Diagnostics, Inc, Foundation Medicine, Inc, Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG), Genomic Health, Myriad Genetics, Inc, Thermo Fisher Scientific, Inc, QIAGEN NV, Bio-Rad Laboratories Inc, Menarini-Silicon Biosystems, GRAIL

select a license
Single User License
USD 2490 INR 171810
Hard Copy License
USD 3190 INR 220110
CD-Rom
USD 2690 INR 185610
Site License
USD 3190 INR 220110
Corporate User License
USD 3190 INR 220110

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com